Results 11 to 20 of about 1,553,841 (335)

Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges

Journal of Clinical Medicine, 2022
Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare and highly aggressive type of lung cancer, with a complex biology that shares similarities with both small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC).
Elisa Andrini, P. Marchese, D. de Biase, C. Mosconi, G. Siepe, F. Panzuto, A. Ardizzoni, D. Campana, G. Lamberti   +8 more
semanticscholar   +1 more source

Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma

JAMA Network Open, 2021
Key Points Question Are there any differences in prognoses or recurrence patterns associated with gastric neuroendocrine carcinoma, mixed adenoneuroendocrine carcinoma, or adenocarcinoma?
Jianxian Lin, Yajun Zhao, Yanbing Zhou, Yantao Tian, Qing-Liang He, Junpeng Lin, H. Hao, Bingbing Zou, Lixin Jiang, Gang Zhao, Wei Lin, Yan-chang Xu, Zhi Li, Fangqin Xue, Shuliang Li, W. Fu, Yongxiang Li, Zekuan Xu, Yong Li, Jinping Chen, Xiaojun Zhou, Zheng‐gang Zhu, Lisheng Cai, En Li, Honglang Li, C. Zheng, Ping Li, Chang-ming Huang, Jian-Wei Xie   +28 more
semanticscholar   +1 more source

Management of Large Cell Neuroendocrine Carcinoma

Frontiers in Oncology, 2021
Background Large cell neuroendocrine carcinoma (LCNEC) is a rare, aggressive cancer with a dismal prognosis. The majority of cases occur in the lung and the gastrointestinal tract; however, it can occur throughout the body.
Virginia Corbett, S. Arnold, L. Anthony, A. Chauhan   +3 more
semanticscholar   +1 more source

Primary Laryngeal Neuroendocrine Carcinoma – A Rare Entity with Deviant Clinical Presentation [PDF]

Journal of Clinical and Diagnostic Research, 2014
Primary laryngeal neuroendocrine carcinomas are rare neoplasms. WHO classifies them under five categories of which, the moderately differentiated neuroendocrine carcinoma is synonymous with atypical or malignant carcinoid tumour.
Hemalatha A. L, Anoosha K, Amita K, Vijay Shankar S, Avadhani Geeta K   +4 more
doaj   +1 more source

Mixed Neuroendocrine Carcinoma and Hepatocellular Carcinoma: A Case Report and Literature Review

Frontiers in Surgery, 2021
Background: Neuroendocrine tumors are heterogeneous malignancies that originate from the neuroendocrine system. Previous studies show that this cancer type mainly localizes in the gastrointestinal tract and often metastasizes to the liver.
Jianwei Lan, Deliang Guo, Xian Qin, Baiyang Chen, Quanyan Liu, Quanyan Liu   +5 more
doaj   +1 more source

The Clinical and Uropathological Aspects of Neuroendocrine Tumours of the Bladder: A Review

Journal of Urological Surgery, 2021
Neuroendocrine tumours of the bladder are less common than other histologic types (e.g., urothelial carcinoma, squamous cell carcinoma, adenocarcinoma), constituting 1% of malignant bladder cancers.
Büşra Yaprak Bayrak
doaj   +1 more source

Vaginal Neuroendocrine Carcinoma [PDF]

Definitions, 2020
openaire   +2 more sources

Vulvar neuroendocrine carcinoma that is independent of merkel cell polyomavirus and human papillomavirus suggests endometrial cancer recurrence: a case report

BMC Endocrine Disorders, 2022
Background Vulvar neuroendocrine carcinomas with small cell morphology need an appropriate differential diagnosis with respect to primary Merkel cell carcinomas, primary small cell neuroendocrine carcinomas, and secondary/metastatic carcinomas.
Tomoko Hirakawa, Mitsutake Yano, Haruto Nishida, Shimpei Sato, Kaei Nasu   +4 more
doaj   +1 more source

New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts

Translational Lung Cancer Research, 2020
Large cell neuroendocrine carcinoma (LCNECs) and small cell lung carcinomas (SCLCs) are high-grade neuroendocrine carcinomas of the lung with very aggressive behavior and poor prognosis.
S. Lantuejoul, L. Fernandez-Cuesta, F. Damiola, N. Girard, Anne McLeer   +4 more
semanticscholar   +1 more source

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma

Experimental Hematology & Oncology, 2020
Pancreatic cancer is one of the most common causes of cancer-related deaths worldwide. The two major histological subtypes of pancreatic cancer are pancreatic ductal adenocarcinoma (PDAC), accounting for 90% of all cases, and pancreatic neuroendocrine ...
Heli Gao, Wen-quan Wang, Xianjun Yu, Liang Liu   +3 more
semanticscholar   +1 more source